Alliancebernstein L.P. Ardelyx, Inc. Transaction History

Alliancebernstein L.P.

$300 Billion
Q3 2025

A detailed history of Alliancebernstein L.P. transactions in Ardelyx, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 267,340 shares of ARDX stock, worth $1.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

267,340

Previous 263,840 1.33%

Holding current value

$1.57 Million

Previous $1.03 Million 42.65%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$3.92 - $6.64 $13,720 - $23,240	3,500 Added 1.33%	267,340 $1.48 Million
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $262,340 - $414,667	44,540 Added 20.31%	263,840 $1.96 Million
Q2 2023 Aug 15, 2023	BUY	$3.23 - $4.95 $708,339 - $1.09 Million	219,300 New	219,300 $743,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $1.17 $30,549 - $70,083	-59,900 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.65 - $1.18 $195 - $354	300 Added 0.5%	59,900 $64,000

Q3 2021 Nov 10, 2021	SELL	$1.27 - $8.17 $18,288 - $117,648	-14,400 Reduced 19.46%	59,600 $79,000
Q2 2021 Jul 30, 2021	BUY	$6.55 - $8.98 $66,155 - $90,698	10,100 Added 15.81%	74,000 $561,000
Q1 2021 May 06, 2021	SELL	$6.1 - $7.69 $54,900 - $69,210	-9,000 Reduced 12.35%	63,900 $423,000
Q2 2020 Aug 13, 2020	BUY	$5.37 - $8.11 $43,497 - $65,691	8,100 Added 12.5%	72,900 $504,000
Q1 2020 May 14, 2020	BUY	$4.35 - $8.79 $128,324 - $259,304	29,500 Added 83.57%	64,800 $368,000
Q3 2019 Nov 14, 2019	SELL	$2.15 - $6.28 $30,315 - $88,548	-14,100 Reduced 28.54%	35,300 $166,000
Q2 2019 Aug 14, 2019	BUY	$2.49 - $3.73 $7,470 - $11,190	3,000 Added 6.47%	49,400 $133,000
Q1 2019 May 14, 2019	SELL	$1.88 - $3.35 $12,220 - $21,775	-6,500 Reduced 12.29%	46,400 $130,000
Q3 2018 Nov 08, 2018	BUY	$3.75 - $4.65 $15,000 - $18,600	4,000 Added 8.18%	52,900 $230,000
Q2 2018 Aug 13, 2018	BUY	$3.7 - $5.8 $58,460 - $91,640	15,800 Added 47.73%	48,900 $181,000
Q4 2017 Feb 13, 2018	SELL	$4.85 - $7.8 $132,890 - $213,720	-27,400 Reduced 45.29%	33,100 $218,000
Q3 2017 Nov 13, 2017	BUY	$4.35 - $5.7 $263,175 - $344,850	60,500	60,500 $339,000

Others Institutions Holding ARDX

# of Institutions

245

Shares Held

161M

Call Options Held

697K

Put Options Held

1.61M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $908M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Ardelyx, Inc. Transaction History